North America Gait Rehabilitation System Market

The North America gait rehabilitation system market is expected to reach US$ 192.4 million by 2028 from US$ 127.1 million in 2021.

The market is estimated to grow at a CAGR of 6.1% from 2021–2028. The escalating prevalence of joint and orthopedic diseases has also been triggering the demand for joint pain therapy and muscle ailment relief procedures. As per the World Health Organization (WHO) factsheet updated in 2018, musculoskeletal conditions are the second-largest contributor to disabilities worldwide. Moreover, the prevalence and impact of these disorders are expected to rise with the increase in the aging population and rise in many risk factors associated with noncommunicable diseases (NCDs). Further, osteoarthritis (OA), caused by the breakdown of joint cartilage between bones, is one of the most common joint disorders reported in the US. It is also known as degenerative joint disease or “wear and tear” arthritis. As per the Centers for Disease Control and Prevention (CDC), more than 32.5 million adults in the US suffer from OA. According to the National Health Service (NHS) data December 2018, more than 10 million people in the UK have arthritis or similar conditions affecting joints. Gait rehabilitation systems are the primary therapy devices used by people from all age groups, generally without seeking a physician's prescription. Thus, the elevating number of people suffering from sports injuries and orthopedic diseases is contributing to the North America gait rehabilitation system market growth.

Due to the spread of the coronavirus, many cities are being closed, resulting in treatments and cancellations from doctors/surgeons. The patients suffering from critical surgeries such as neurosurgery, spine surgery, and ENT surgery need to be physically conscious and implement procedures in the clinics. Since the coronavirus outbreak reached a pandemic status, the entire North America supply chain has been affected, which has disrupted logistics and production capacities. As a result, COVID-19 has had a significant negative impact on the gait rehabilitation systems market. The COVID-19 pandemic can deprive patients with neurological diseases of their usual care. During the pandemic, there was a tendency towards home exercise programs due to the limited duration of therapy and access to physical therapy. Self-rehabilitation at home is an increasingly common part of rehabilitation programs, especially for various long-term illnesses such as MS.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the gait rehabilitation system market. The North America gait rehabilitation system market is expected to grow at a good CAGR during the forecast period.

North America Gait Rehabilitation System Market Revenue and Forecast to 2028 (US$ Million)

North America Gait Rehabilitation System Market Segmentation         

By Product Type

• Mechanical Type
• Computer-aided

By End User

• Hospitals
• Rehabilitation Centers
• Clinics
• Others

By Country

• North America
• US
• Canada
• Mexico

Companies Mentioned

• zebris Medical GmbH
• PRODROMUS S.A.
• Reha Technology AG
• DIH Medical
• Meditouch
• HIWIN Corporation
• Restorative Therapies, Inc.
• Meden-Inmed Sp. z o.o.
• Groupe WINNCARE 

North America Gait Rehabilitation System Market Strategic Insights

North America Gait Rehabilitation System Market Segmentation Analysis

North America Gait Rehabilitation System Market Report Highlights

North America Gait Rehabilitation System Report Scope

North America Gait Rehabilitation System Market Country and Regional Insights